Use of double cells to power an implantable medical device

• US 6,008,625 A
• Filed: 01/16/1998
• Issued: 12/28/1999
• Est. Priority Date: 01/16/1998
• Status: Expired due to Fees

• Current Assignee: Greatbatch Limited (Greatbatch Incorporated)
• Original Assignee: Wilson Greatbatch Technologies, Inc.
• Inventors: Gan, Hong, Takuchi, Esther S.
• Primary Examiner(s): Wong, Peter S.
• Assistant Examiner(s): TOATLEY, GREGORY J
• Application Number:
  US09/008,469
• Time in Patent Office: 711 Days
• Field of Search: 320/127, 320/129, 320/135, 600/16, 600/17
• US Class Current: 320/129
• CPC Class Codes: A61N 1/378 Electrical supply
• CPC Class Codes: H01M 2300/0037 Mixture of solvents
• CPC Class Codes: H01M 4/134 Electrodes based on metals, Si or alloys
• CPC Class Codes: H01M 4/483 for non-aqueous cells H01M4/485 takes precedence
• CPC Class Codes: H01M 4/5815 Sulfides
• CPC Class Codes: H01M 6/16 with organic electrolyte H01M6/18 takes precedence
• CPC Class Codes: H01M 6/164 by the solvent
• CPC Class Codes: H01M 6/166 by the solute
• CPC Class Codes: H01M 6/42 Grouping of primary cells into batteries H01M6/40 takes precedence
• CPC Class Codes: H01M 6/50 Methods or arrangements for servicing or maintenance, e.g. for maintaining operating temperature constructional details of current conducting connections for detecting conditions inside cells or batteries, e.g. details of voltage sensing terminals, H01M50/569
• CPC Class Codes: H01M 6/5016 Multimode utilisation
• CPC Class Codes: Y02E 60/10 Energy storage using batteries

Abstract

A power source including two alkali metal/transition metal oxide cells discharged in parallel to power an implantable medical device is described. The first cell powers the medical device in both a device monitoring mode, for example in a cardiac defibrillator for monitoring the heart beat, and a device actuation mode for charging capacitors requiring high rate electrical pulse discharging. At such time as the first cell is discharged to a predetermined voltage limit, the first cell is disconnected from pulse discharge duty and only used for the device monitoring function. At that time, the second cell is utilized for the high rate electrical pulse discharging function. When the first cell reaches 100% efficiency or a present voltage limit, the second cell then takes over both device monitoring and device actuation functions. In that manner, a greater average discharge efficiency is realized from the two cells than is capable of being delivered from a single cell of similar chemistry.

Claims

1. In combination with an electrical load requiring a substantially constant discharge current during a monitoring function and at least one current pulse discharge for an operating function, at least two electrochemical cells connected in parallel, which comprises:

a) a first electrochemical cell serving as a first power source for the electrical load, wherein the first cell is dischargeable to deliver a first substantially constant discharge current interruptible from time-to-time to deliver a first current pulse discharge;

b) a second electrochemical cell serving as a second power source for the electrical load, wherein the second cell is dischargeable to deliver a second substantially constant discharge current interruptible from time-to-time to deliver a second current pulse discharge; and

c) a switch coupled between the first and second cells and the electrical load, wherein the switch is actuatable to initially connect the first cell to the electrical load as the sole power source for the monitoring function and the operating function until the first cell'"'"'s energy capacity is depleted to a first predetermined threshold where it is no longer capable of delivering a current pulse discharge and wherein the switch is then actuatable to connect the second cell to the electrical load as the power source for the operating function while the first cell continues to provide the power for the monitoring function, wherein the switch is then actuatable at such time as the first cell'"'"'s energy capacity is depleted to a second predetermined threshold to disconnect the first cell from the electrical load.

2. The combination of claim 1 wherein the first and second cells are each dischargeable to provide at least two current pulses delivered in succession with or without an open circuit period between the pulses during the medical device operating function.

3. The combination of claim 2 wherein the current pulses are of about 23.2 mA/cm².

4. The combination of claim 1 wherein the first and second cells each comprise a lithium anode and a solid cathode.

5. The combination of claim 1 wherein for each of the cells, the anode comprises lithium anode active material in electrical contact with a nickel current collector and the cathode comprises silver vanadium oxide active material in electrical contact with a titanium current collector and wherein the anode and the cathode are activated with the electrolyte solution comprising 1.0 M LiAsF₆ in a 50:

50 mixture, by volume, of propylene carbonate and 1,2-dimethoxyethane.

6. The combination of claim 1 wherein the second cell has less discharge capacity than the first cell before the cells are discharged.

7. The combination of claim 1 wherein the two cells are housed in a common casing.

8. The combination of claim 1 wherein the first and second substantially constant discharge current are about 1 microampere to about 100 milliamperes.

9. The combination of claim 1 wherein the first and second current pulse discharges are about 1 ampere to about 4 amperes.

10. The combination of claim 1 wherein the first and second substantially constant discharge current are about 1 microampere to about 100 milliamperes and the first and second current pulse discharges are of at least about 1 ampere.